Effect of Fresh Gas Flow on Emergence Time

August 16, 2022 updated by: Young-Kug Kim, MD, Asan Medical Center

Effect of Fresh Gas Flow on Emergence Time in the Patients Undergoing Transurethral Resection of Bladder Tumor: A Randomized Controlled Clinical Trial

The purpose of this study is to evaluate the effect of fresh gas flow on emergence time in patients undergoing transurethral resection of bladder tumor.

Study Overview

Detailed Description

The purpose of this study is to evaluate the effect of fresh gas flow (5 L/min vs. 10 L/min) on emergence time in patients undergoing transurethral resection of bladder tumor.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who are scheduled transurethral resection of bladder tumor under general anesthesia
  • Patients aged between 20 and 79 years old
  • American Society of Anesthesiologists physical status ≤2
  • Patients who are voluntarily agreed to this clinical study

Exclusion Criteria:

  • A long operation (2 hours or longer)
  • Hearing disturbance
  • Cognitive disorder
  • Psychiatric substance abuse
  • Patient's denial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group Five
For emergence from general anesthesia, a fresh gas flow of 5 L/min is used.
A fresh gas flow of 5 L/min is used during emergence from general anesthesia.
Experimental: Group Ten
For emergence from general anesthesia, a fresh gas flow of 10 L/min is used.
A fresh gas flow of 10 L/min is used during emergence from general anesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emergence time
Time Frame: From end of surgery to extubation (assessed up to 30 minutes after surgery)
When consciousness and self respiration are fully recovered after surgery is ended, extubation is tried. The time to extubation (emergence time) is recorded.
From end of surgery to extubation (assessed up to 30 minutes after surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to spontaneous movement
Time Frame: From end of surgery to spontaneous movement (assessed up to 30 minutes after surgery)
After surgery is stopped, the patients are asked to open their eyes every 1 minute after the termination of sevoflurane administration. The time to spontaneous movement is recorded.
From end of surgery to spontaneous movement (assessed up to 30 minutes after surgery)
Time to eye opening
Time Frame: From end of surgery to eye opening (assessed up to 30 minutes after surgery)
After surgery is stopped, the patients are asked to open their eyes every 1 minute after the termination of sevoflurane administration. The time to eye opening is recorded.
From end of surgery to eye opening (assessed up to 30 minutes after surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2022

Primary Completion (Actual)

August 16, 2022

Study Completion (Actual)

August 17, 2022

Study Registration Dates

First Submitted

May 9, 2022

First Submitted That Met QC Criteria

May 11, 2022

First Posted (Actual)

May 17, 2022

Study Record Updates

Last Update Posted (Actual)

August 18, 2022

Last Update Submitted That Met QC Criteria

August 16, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bladder Cancer

Clinical Trials on Fresh gas flow of 5 L/min

Subscribe